| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/31/2008 | WO2008013791A2 Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal |
| 01/31/2008 | WO2008013773A2 Quinine products, method of manufacture, and method of use |
| 01/31/2008 | WO2008013764A2 Method for prevention and treatment of alzheimers |
| 01/31/2008 | WO2008013743A2 Methods for inhibiting reperfusion injury |
| 01/31/2008 | WO2008013733A2 Porous plastic smoking cessation devices |
| 01/31/2008 | WO2008013710A2 Chewable tablet containing phenylephrine |
| 01/31/2008 | WO2008013669A2 Alpha hydroxy acid sustained release formulation |
| 01/31/2008 | WO2008013660A2 Inhibitors of advanced glycation end products |
| 01/31/2008 | WO2008013633A2 Treating sex steroid responsive disorders |
| 01/31/2008 | WO2008013631A2 Composition for the enterosorption and management of toxins comprising a calcium aluminosilcilate clay |
| 01/31/2008 | WO2008013622A2 Fungicidal azocyclic amides |
| 01/31/2008 | WO2008013618A1 Process for preparing alkyne intermediates for dendritic polymers |
| 01/31/2008 | WO2008013589A2 Treatment of ras-expressing tumors |
| 01/31/2008 | WO2008013573A1 Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory |
| 01/31/2008 | WO2008013494A1 Quinoline derivatives as p2x7 receptor antagonist and their use in the treatment of rheumatoid arthritis, osteoarthritis, copd and ibd |
| 01/31/2008 | WO2008013342A1 Cosmetic composition for exfoliating skin keratin |
| 01/31/2008 | WO2008013336A1 Pyripyropene derivatives and insecticidal compositions comprising them |
| 01/31/2008 | WO2008013334A1 Deformylase inhibitor, process for the preparation thereof, and composition comprising the same |
| 01/31/2008 | WO2008013324A1 Use of diabetes-related, liver-derived secreted protein in diagnosis or treatment of type-2 diabetes or vascular disorder |
| 01/31/2008 | WO2008013322A1 1- (-d-glycopyranosyl) - 3 - (4-cyclopropylphenylmethyl) - 4 - halogeno indole derivatives and use thereof as sglt inhibitors. |
| 01/31/2008 | WO2008013321A1 Novel sglt inhibitors |
| 01/31/2008 | WO2008013280A1 Substituted spiroketal derivative and use thereof as drug for treating diabetes |
| 01/31/2008 | WO2008013277A1 Fused ring spiroketal derivative and use thereof as drug for treating diabetes |
| 01/31/2008 | WO2008013248A1 Process for production of (±)-trans-4-(4- fluorophenyl)-3-hydroxymethylpiperidine |
| 01/31/2008 | WO2008013235A1 Method of removing parasites on body surface of fishes |
| 01/31/2008 | WO2008013219A1 Oral composition enabling increased absorption of cryptoxanthin |
| 01/31/2008 | WO2008013215A1 Sleep-inducing oral preparation, and oral preparation for amelioration of stress-induced insomnia |
| 01/31/2008 | WO2008013213A1 Prodrug of cinnamide compound |
| 01/31/2008 | WO2008013197A1 Spherical crude granule and method for production thereof |
| 01/31/2008 | WO2008013062A1 Methioninase inhibitor and composition and food or drink containing the same |
| 01/31/2008 | WO2008012952A1 Composition for stimulation of metabolism |
| 01/31/2008 | WO2008012945A1 3'-ethynylcytidine derivative |
| 01/31/2008 | WO2008012932A1 Insulin resistance reducer |
| 01/31/2008 | WO2008012782A2 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 01/31/2008 | WO2008012666A2 Treatment and prevention mucositis by anthocyanidin derivatives |
| 01/31/2008 | WO2008012645A2 Use of vitamin d3 agonist in a mammalian model for atopic diseases and of vitamin d3 antagonists for the treatment of atopic diseases |
| 01/31/2008 | WO2008012635A2 Amine derivatives useful as anticancer agents |
| 01/31/2008 | WO2008012628A1 A preparation for infertility treatment |
| 01/31/2008 | WO2008012623A1 Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor |
| 01/31/2008 | WO2008012622A2 Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor |
| 01/31/2008 | WO2008012621A2 Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi |
| 01/31/2008 | WO2008012583A2 Cyclohexenone and cyclohexanone derivatives |
| 01/31/2008 | WO2008012571A1 Imidazothiazole derivatives as mark inhibitors |
| 01/31/2008 | WO2008012563A2 Use of cdk inhibitors for the treatment of granulocyte mediated disorders |
| 01/31/2008 | WO2008012540A1 N-terminal polysialylation |
| 01/31/2008 | WO2008012534A2 Retinoids and small molecules as nrf2 antagonists for use in the treatment of diseases associated with abnormal cell proliferation |
| 01/31/2008 | WO2008012532A2 : pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase |
| 01/31/2008 | WO2008012524A1 Substituted aniline derivatives |
| 01/31/2008 | WO2008012511A1 Compounds having crth2 antagonist activity |
| 01/31/2008 | WO2008012495A1 Pharmaceutical formulation comprising donepezil |
| 01/31/2008 | WO2008012474A2 Pharmaceutical compositions of active substances difficult to improperly divert from their intended route of administration |
| 01/31/2008 | WO2008012441A2 Linear pyridazine and pyrrole compounds, processes for obtaining them and uses |
| 01/31/2008 | WO2008012418A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/31/2008 | WO2008012372A1 Process for the preparation of candesartan cilexetil form i |
| 01/31/2008 | WO2008012371A1 Process for the preparation of amorphous and crystalline forms of candesartan cilexetil using column chromatography |
| 01/31/2008 | WO2008012361A2 Dimethano-[1,3] dioxocino [6,5-d] pyrimidine-spiro derivatives of tetrodotoxin, process for their synthesis and uses thereof in the treatment of pain |
| 01/31/2008 | WO2008012346A1 Extended release pharmaceutical formulation of metoprolol and process for its preparation |
| 01/31/2008 | WO2008012344A1 Naphthalene derivatives used as ep4 receptor agonists |
| 01/31/2008 | WO2008012338A2 Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions |
| 01/31/2008 | WO2008012326A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/31/2008 | WO2008012227A2 Pyrazoles as glucokinase activators |
| 01/31/2008 | WO2008012107A2 Use of polyethylene glycol in inflammatory skin conditions and wound healing |
| 01/31/2008 | WO2008012105A1 Crystalline erlotinib |
| 01/31/2008 | WO2008012089A2 Polyphenol/peptide composition and use thereof for promoting gastric health |
| 01/31/2008 | WO2008012062A1 Antigenic proteoliposomes and method of manufacture |
| 01/31/2008 | WO2008012031A2 Blockers of gsk3 for the prevention and treatment of pemphigus vulgaris |
| 01/31/2008 | WO2008012010A1 Fused oxazoles & thiazoles as histamine h3- receptor ligands |
| 01/31/2008 | WO2008012003A1 Camptothecin derivatives with antitumor activity |
| 01/31/2008 | WO2008011994A1 Camptothecin derivatives with antitumor activity |
| 01/31/2008 | WO2008011992A1 Camptothecin derivatives with antitumor activity |
| 01/31/2008 | WO2008011980A1 Preparation of antimicrobial formulations using 7-oxa-2-thia-1,5-diazabicyclo[3.3.1]nonane-2,2-dione |
| 01/31/2008 | WO2008011836A2 Ophthalmic solutions |
| 01/31/2008 | WO2008011805A1 Vinblastines compounds, the preparation and the pharmaceutical use thereof |
| 01/31/2008 | WO2008011799A1 NEW USE OF NON-RECEPTOR TYROSINE KINASE c-Ab1 SPECIFIC INHIBITORS |
| 01/31/2008 | WO2008011709A1 Biomarkers for use in the diagnosis and treatment of colorectal cancer |
| 01/31/2008 | WO2008011700A1 Compositions and Methods for Alleviating Joint Pain and Improving Joint Flexibility |
| 01/31/2008 | WO2008011670A1 Trauma therapy |
| 01/31/2008 | WO2007149395A3 2,5-substituted oxazole derivatives as protein kinase inhibitors for the treatment of cancer |
| 01/31/2008 | WO2007140297A3 Aziridinyl-epothilone compounds |
| 01/31/2008 | WO2007140005A3 Oxazolyl piperidine modulators of fatty acid amide hydrolase |
| 01/31/2008 | WO2007139833A3 Imidazoazephinone compounds |
| 01/31/2008 | WO2007139827A3 Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses |
| 01/31/2008 | WO2007138022A3 Lipoic acid pellets |
| 01/31/2008 | WO2007137864A9 Use of inhibitors of pp2c for treating or preventing arteriosclerosis |
| 01/31/2008 | WO2007136586A3 Personal care compositions |
| 01/31/2008 | WO2007131488A3 Use of quinoline derivatives as anti-protozoal agent and in combination preparations |
| 01/31/2008 | WO2007131310B1 Anti-inflammatory and analgesic pharmaceutical composition containing safrole n-acylhydrazone derivatives, use, and method of preparation |
| 01/31/2008 | WO2007127448A3 Salts of pyridazine compounds |
| 01/31/2008 | WO2007125295A3 Treatment of hypothyroidism |
| 01/31/2008 | WO2007124045A3 Piperidine and piperazine compounds for use in the treatment of obesity, eating disorders and sexual dysfunction by potentiation of mc4 receptor activity |
| 01/31/2008 | WO2007123892A3 Raf inhibitors and their uses |
| 01/31/2008 | WO2007120574A3 Diaryl substituted alkanes |
| 01/31/2008 | WO2007119116A3 Improved synthesis and preparations of duloxetine salts |
| 01/31/2008 | WO2007109459A3 Pyridines and pyridine n-oxides as modulators of thrombin |
| 01/31/2008 | WO2007102770A8 Gsk-3 inhibitors for the treatment of osteoporosis |
| 01/31/2008 | WO2007100282A8 New salts of an indole derivative and their use in medicine |
| 01/31/2008 | WO2007098507A3 Compositions and methods for inhibition of the jak pathway |
| 01/31/2008 | WO2007095605A3 Method for accelerating reentrainment of a circadian rhythm |
| 01/31/2008 | WO2007094962A3 Pyrazoles for the treatment of obesity and other cns disorders |
| 01/31/2008 | WO2007094669A3 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation |